After the initial 1-17.5c ride almost 3 months ago I'm sure many here are eager for the big news.
US agreements and distribution planned for FebriDx by end of this year, so who knows the timing. Other news is likely also like ViraDx agreements and other FebriDx agreements or sales in countries other than America. Even first sales news will likely be coming in the next quarterly along with hopefully further improved sales revenue in general from the company.
Certainly undervalued, but I guess the market is just waiting to see the news before taking the brake off.
Add to My Watchlist
What is My Watchlist?
